search
Back to results

Study of the Biological Function of Muscle Satellite Cells From Patients With Obstetric Brachial Plexus Palsy (SCOPE)

Primary Purpose

Obstetrical Brachial Plexus Palsy

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Muscle biopsy
Sponsored by
University Hospital, Montpellier
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Obstetrical Brachial Plexus Palsy focused on measuring Brachial plexus, Neonatal brachial plexus palsy, Denervation, Muscle atrophy, Muscle regeneration, Botulinum toxin, Satellite cell, Primary human muscle cell culture

Eligibility Criteria

2 Years - 15 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • OBPP children with a planned shoulder surgery (arthrolysis and/or muscle transfer).

Exclusion Criteria:

  • other neurological disorders, post-traumatic shoulder stiffness

Sites / Locations

  • Chu MontpellierRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

OBPP children

Arm Description

OBPP children operated on to treat shoulder stiffness.

Outcomes

Primary Outcome Measures

Assessment of muscle regeneration capacity: proliferation capacity
Proliferation capacity of satellite cells assessed by immunofluorescence: percentage of Pax 7 positive cells/total desmin positive cells
assessment of muscle regeneration capacity: differenciation capacity
Differentiation capacity of satellite cells assessed by histology: fusion index (number of nuclei in a myotubule compared to total number of nuclei in the sample) in percentage

Secondary Outcome Measures

Effect of botulinum toxin on the proliferation potential of satellite cells: proliferation capacity
Proliferation capacity of satellite cells assessed by immunofluorescence: percentage of Pax 7 positive cells/total desmin positive cells.
Effect of botulinum toxin on the proliferation potential of satellite cells: differentiation capacity
Differentiation capacity of satellite cells assessed by histology: fusion index (number of nuclei in a myotubule compared to total number of nuclei in the sample) in percentage

Full Information

First Posted
April 26, 2022
Last Updated
May 2, 2023
Sponsor
University Hospital, Montpellier
Collaborators
PhyMedExp Inserm U1046
search

1. Study Identification

Unique Protocol Identification Number
NCT05403034
Brief Title
Study of the Biological Function of Muscle Satellite Cells From Patients With Obstetric Brachial Plexus Palsy
Acronym
SCOPE
Official Title
Study of the Biological Function of Muscle Satellite Cells From Patients With Obstetric Brachial Plexus Palsy Satellite Cell Obstetrical PlExus (SCOPE)
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 17, 2022 (Actual)
Primary Completion Date
October 17, 2026 (Anticipated)
Study Completion Date
October 17, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Montpellier
Collaborators
PhyMedExp Inserm U1046

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this prospective work is to study the consequences of obstetrical brachial plexus paralysis on the rotator muscles of the shoulder. The hypothesis is that shoulder stiffness of these children is due to an impairment of the shoulder rotator muscles. The investigators want to test the regenerative capacities of these muscles. The development of a cellular model of this pathology will allow to test new therapeutic perspectives and to validate our hypothesis.
Detailed Description
During delivery, there can be a lesion of the nerve roots of the brachial plexus (cervical C5-C8 and/or thoracic T1 roots). The newborn presents at birth a paralysis of the arm (Obstetrical Brachial Plexus Paralysis: OBPP). One third of children with OBPP will have sequelae despite daily rehabilitation. The most frequent disability is shoulder stiffness. The current hypothesis is that this stiffness is due to a permanent imbalance between the affected shoulder muscles (lateral rotators) and the muscles less affected by the paralysis (medial rotators). Because of this imbalance, the injured shoulder is spontaneously positioned in medial rotation. This position would lead to retractions at the front of the joint despite rehabilitation. In case of incomplete recovery, growth disorders of the shoulder joint (dysplasia) appear as well as a functional handicap. The management, from the age of 2 years, in case of shoulder stiffness and dysplasia, is surgery (arthrolysis) to regain mobility. During this operation, a muscle transfer can also be performed to strengthen the lateral rotator muscles. However, despite surgery, mobility deficits often recur within a few years. To understand the origin of the lateral and medial rotation deficits, the investigators conducted an anatomopathological study of the rotator muscles in these children. The preliminary results show a significant damage of the rotator muscles with the presence of fibrosis which could explain the rotational stiffness and the functional impairment. To better understand the pathophysiological mechanisms, the investigatorswill set up an OBPP model in cell culture to understand the regenerative capacities and to test new pharmacological approaches.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obstetrical Brachial Plexus Palsy
Keywords
Brachial plexus, Neonatal brachial plexus palsy, Denervation, Muscle atrophy, Muscle regeneration, Botulinum toxin, Satellite cell, Primary human muscle cell culture

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
8 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
OBPP children
Arm Type
Experimental
Arm Description
OBPP children operated on to treat shoulder stiffness.
Intervention Type
Procedure
Intervention Name(s)
Muscle biopsy
Other Intervention Name(s)
Shoulder arthrolysis, Shoulder muscle transfer
Intervention Description
Peroperative muscle biopsy will be performed during a planned shoulder surgery (arthrolysis and/or muscle transfer)
Primary Outcome Measure Information:
Title
Assessment of muscle regeneration capacity: proliferation capacity
Description
Proliferation capacity of satellite cells assessed by immunofluorescence: percentage of Pax 7 positive cells/total desmin positive cells
Time Frame
30 days
Title
assessment of muscle regeneration capacity: differenciation capacity
Description
Differentiation capacity of satellite cells assessed by histology: fusion index (number of nuclei in a myotubule compared to total number of nuclei in the sample) in percentage
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Effect of botulinum toxin on the proliferation potential of satellite cells: proliferation capacity
Description
Proliferation capacity of satellite cells assessed by immunofluorescence: percentage of Pax 7 positive cells/total desmin positive cells.
Time Frame
30 days
Title
Effect of botulinum toxin on the proliferation potential of satellite cells: differentiation capacity
Description
Differentiation capacity of satellite cells assessed by histology: fusion index (number of nuclei in a myotubule compared to total number of nuclei in the sample) in percentage
Time Frame
30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
15 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: OBPP children with a planned shoulder surgery (arthrolysis and/or muscle transfer). Exclusion Criteria: other neurological disorders, post-traumatic shoulder stiffness
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Marion DELPONT, Dr
Phone
+33 467335035
Email
m-delpont@chu-montpellier.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marion DELPONT, Dr
Organizational Affiliation
University Hospital, Montpellier
Official's Role
Principal Investigator
Facility Information:
Facility Name
Chu Montpellier
City
Montpellier
ZIP/Postal Code
34000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marion DELPONT, PhD
Phone
0467339581
Email
m-delpont@chu-montpellier.fr

12. IPD Sharing Statement

Learn more about this trial

Study of the Biological Function of Muscle Satellite Cells From Patients With Obstetric Brachial Plexus Palsy

We'll reach out to this number within 24 hrs